Literature DB >> 28362211

Laser interstitial thermal therapy for palliative ablation of a chordoma metastasis to the spine: case report.

Brian J Williams1, Patrick J Karas1, Ganesh Rao1, Laurence D Rhines1, Claudio E Tatsui1.   

Abstract

The authors present the first report of laser interstitial thermal therapy (LITT) ablation of a recurrent chordoma metastasis to the cervical spine. This patient was a 75-year-old woman who was diagnosed and treated for a sacral chordoma, and then developed metastases to the lung and upper thoracic spine. Unfortunately she experienced symptomatic recurrence at the C-7 spinous process. She underwent an uncomplicated LITT to the lesion. The patient convalesced without incident and was discharged on postoperative Day 1. She received stereotactic spinal radiosurgery to the lesion at a dose of 24 Gy in 1 fraction. At the 3-month follow-up evaluation she had radiographic response and improvement in her symptoms.

Entities:  

Keywords:  IMRT = intensity-modulated radiation therapy; LITT = laser interstitial thermal therapy; SRS = stereotactic radiosurgery; ablation; chordoma; laser interstitial thermal therapy; metastasis; oncology

Mesh:

Year:  2017        PMID: 28362211     DOI: 10.3171/2016.11.SPINE16897

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  3 in total

Review 1.  Thermal Ablation of Bone Metastases.

Authors:  Michael R Moynagh; A Nicholas Kurup; Matthew R Callstrom
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

2.  Exophytic Lumbar Vertebral Body Mass in an Adult with Back Pain.

Authors:  J C Benson; M A Vizcaino; D K Kim; C Carr; P Rose; L Eckel; F Diehn
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

3.  Surgical treatment of giant chordoma in the thoracic spine combining thoracoscopic and posterior spinal surgery: A case report.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Siyuan Yao; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.